BVRS-GamVac-Combi / Gamalei Institute of Epidemiology and Microbiology - LARVOL DELTA

Study of Safety and Immunogenicity of BVRS-GamVac-Combi (clinicaltrials.gov) - P1/2; N=268; Recruiting; Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation; Trial completion date: Dec 2020 ➔ Dec 2021; Trial primary completion date: Dec 2020 ➔ Jul 2021

Clinical • Trial completion date • Trial primary completion date • Respiratory Diseases